Abbott, Novartis, Pfizer Reportedly Submit Bids For Brazil's Ache
This article was originally published in PharmAsia News
Executive Summary
Brazil's Ache Laboratorios Farmaceuticos reportedly has attracted bids from Abbott Laboratories, Novartis, Pfizer and other large drug makers seeking to buy the country's fourth-largest pharma valued at more than $5 billion.